Thirty-Day Readmissions in Hospitalized Patients Who Received Bezlotoxumab With Antibacterial Drug Treatment for Clostridium difficile Infection.

Link to article at PubMed

Related Articles

Thirty-Day Readmissions in Hospitalized Patients Who Received Bezlotoxumab With Antibacterial Drug Treatment for Clostridium difficile Infection.

Clin Infect Dis. 2017 Oct 01;65(7):1218-1221

Authors: Prabhu VS, Cornely OA, Golan Y, Dubberke ER, Heimann SM, Hanson ME, Liao J, Pedley A, Dorr MB, Marcella S

Abstract
Clinical Trials Registration.: NCT01241552 (MODIFY I) and NCT01513239 (MODIFY II).

PMID: 30060024 [PubMed - in process]

Leave a Reply

Your email address will not be published.